Brentuximab vedotin
Medicine
Cost effectiveness
Palliative care
Lymphoma
Incremental cost-effectiveness ratio
Oncology
Refractory (planetary science)
Hodgkin lymphoma
Internal medicine
Quality-adjusted life year
Nursing
Risk analysis (engineering)
Physics
Astrobiology
